Innovation for Health - 14 February 2019
Global Investor Forum Contact
LinkedIn
Twitter
Facebook
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare
Innovation for Health - Shaping the future of healthcare

Marco de Boer

CEO & Co-founder, NTrans Technologies

Marco de Boer is CEO and co-founder of NTrans Technologies. He contributes his experience in the commercialization of biological and biomedical innovations, which includes the commercial development of platforms for the targeted delivery of bioactive molecules. In addition to his role as COO at Crossbeta Biosciences BV, prior to founding NTrans Technologies, Dr. Marco de Boer held several management positions: Head of Research at to-BBB, Head of Bioprocessing at Kerry I&F, Director Biomolecules at Isogen Life Science, and Research Manager at Unilever Research, Vlaardingen. Marco received an MBA from the Nyenrode Business University.

Sponsors & Partners
Main partner
Health~Holland
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Platinum sponsor
MSD
Platinum sponsor
Janssen Diagnostics - Janssen
Gold sponsor
Medical Delta
Silver sponsor
NLC The Healthtec Venture Builder
Sponsor
Kempen
Award sponsor
AXON Lawyers
Award sponsor
Genmab
Partner
Vereniging Innovatieve Geneesmiddelen
Partner
Global Investor Forum
© 2019 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.